Catalyst Event

Shanghai Fosun Pharmaceutical (Group) Co Ltd (2196) · Earnings Release

From Akros SCHK HK-Global Brain-Computer Interface Index (ASHGBCI)

4/28/2026, 12:00:00 AM

Earnings ReleaseSentiment: Positive

Announced Q1 2026 results on April 28, 2026, with revenue of RMB 10.07 billion (+6.93% YoY) and net profit attributable to shareholders of RMB 871 million (+13.87% YoY). The 13.87% profit growth is estimated to result in a price impact of at least 10% expected.

Korean Translation

2026년 4월 28일, 2026년 1분기 실적을 발표함. 매출은 100.7억 위안(+6.93%), 주주 귀속 순이익은 8.71억 위안(+13.87%)을 기록함. 13.87%의 이익 성장은 10% 이상의 가격 영향을 미칠 것으로 예상됨.

Related Recent Events

View Full Timeline